{"id":"https://openalex.org/W2077465724","doi":"https://doi.org/10.1097/00002371-199307000-00001","title":"Immunomodulatory Effects of Interleukin-12 on Human Tumor-Infiltrating Lymphocytes","display_name":"Immunomodulatory Effects of Interleukin-12 on Human Tumor-Infiltrating Lymphocytes","publication_year":1993,"publication_date":"1993-07-01","ids":{"openalex":"https://openalex.org/W2077465724","doi":"https://doi.org/10.1097/00002371-199307000-00001","mag":"2077465724","pmid":"https://pubmed.ncbi.nlm.nih.gov/8104476"},"language":"en","primary_location":{"id":"doi:10.1097/00002371-199307000-00001","doi":"https://doi.org/10.1097/00002371-199307000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199307000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028066980","display_name":"J. Valerie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Valerie","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111826728","display_name":"Ravan Andrews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravan Andrews","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041688417","display_name":"Deric D. Schoof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deric D. Schoof","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017709484","display_name":"Monica M. Bertagnolli","orcid":"https://orcid.org/0000-0002-0248-3849","observed_orcids":["https://orcid.org/0000-0002-0248-3849"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica M. Bertagnolli","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044161354","display_name":"George Earl Peoples","orcid":"https://orcid.org/0000-0001-7118-8205","observed_orcids":["https://orcid.org/0000-0001-7118-8205"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George E. Peoples","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062157417","display_name":"Peter S. Goedegebuure","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peters S. Goedegebuure","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032371242","display_name":"Timothy J. Eberlein","orcid":"https://orcid.org/0009-0008-7076-2357","observed_orcids":["https://orcid.org/0009-0008-7076-2357"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Eberlein","raw_affiliation_strings":["Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Brigham and Women's Hospital, Department of Surgery, Division of Surgical Oncology, Massachusetts, U.S.A","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1049,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.8888502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"14","issue":"1","first_page":"1","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.23549999296665192,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":1.0},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/t-cell-costimulation","display_name":"T cell costimulation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.7210000157356262},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/mhc-restricted-cytotoxicity","display_name":"MHC-restricted cytotoxicity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/anti-cd3-stimulation","display_name":"anti-CD3 stimulation","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.6776427626609802},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.577477216720581},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5681219100952148},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5609334111213684},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5502047538757324},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5055747032165527},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.49466440081596375},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.49167734384536743},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4522474706172943},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4478677809238434},{"id":"https://openalex.org/C98119934","wikidata":"https://www.wikidata.org/wiki/Q14907167","display_name":"Interleukin 15","level":4,"score":0.4426423907279968},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.37224847078323364},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3590829372406006},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3047138750553131},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06693455576896667}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002371-199307000-00001","doi":"https://doi.org/10.1097/00002371-199307000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199307000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:8104476","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8104476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2506551946","display_name":null,"funder_award_id":"CA 09585","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4422925753","display_name":"ALTERNATIVE METHOD OF ADOPTIVE IMMUNOTHERAPY","funder_award_id":"R01CA045484","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2080042398","https://openalex.org/W1945740511","https://openalex.org/W2017154932","https://openalex.org/W2058327032","https://openalex.org/W2384262848","https://openalex.org/W1988978672","https://openalex.org/W82265677","https://openalex.org/W2382062140","https://openalex.org/W4402538610","https://openalex.org/W1974761216"],"abstract_inverted_index":{"Interleukin":[0],"(IL)-12":[1],"is":[2],"a":[3,59,119],"recently":[4,63],"described":[5],"cytokine":[6],"with":[7,65,104,147,183],"multiple":[8],"immunoregulatory":[9],"effects":[10,30],"on":[11,34,109,167],"various":[12],"lymphoid":[13],"populations,":[14],"including":[15],"peripheral":[16],"blood":[17],"lymphocytes":[18,42],"(PBL),":[19],"natural":[20],"killer":[21],"(NK)":[22],"cells,":[23],"and":[24,73,82,94,126,201],"T-cell":[25],"subsets.":[26],"We":[27],"examined":[28],"the":[29,35,107,141,188],"of":[31,38,53,80,121,124,190,198],"recombinant":[32],"IL-12":[33,56,95,131,148,184],"immune":[36],"function":[37],"human":[39,90],"tumor":[40,47,152],"infiltrating":[41],"(TIL)":[43],"from":[44],"several":[45],"different":[46,128],"types.":[48],"At":[49],"an":[50],"optimal":[51],"concentration":[52],"50":[54],"IU/ml,":[55],"acted":[57],"as":[58,99,171,173],"co-stimulant":[60],"for":[61],"TIL":[62,129,142,145,155,177,191],"activated":[64,105],"anti-CD3":[66],"antibodies,":[67],"giving":[68],"stimulation":[69],"indices":[70],"between":[71],"2.6":[72],"9.9.":[74],"This":[75,113,165],"co-stimulatory":[76],"effect":[77,108,115,166],"was":[78,83,111,169],"independent":[79],"IL-2":[81,93,125],"not":[84,133,170,186],"inhibited":[85],"by":[86],"neutralizing":[87],"antibody":[88],"to":[89],"IL-2.":[91,181],"When":[92],"were":[96],"used":[97,192],"synchronously":[98],"co-mitogenic":[100],"stimuli":[101],"in":[102,127,140,157,176,179,193,204],"culture":[103],"TIL,":[106],"proliferation":[110],"additive.":[112],"additive":[114],"held":[116],"true":[117],"over":[118],"range":[120],"suboptimal":[122],"concentrations":[123],"populations.":[130],"did":[132,185],"enhance":[134],"non-major":[135],"histocompatibility":[136],"complex":[137],"(MHC)-restricted":[138],"cytotoxicity":[139,168],"populations":[143],"tested.":[144],"cultured":[146],"killed":[149],"more":[150],"autologous":[151],"targets":[153],"than":[154],"maintained":[156,178],"media":[158],"alone":[159],"at":[160],"identical":[161],"effector/target":[162],"(E/T)":[163],"ratios.":[164],"great":[172],"that":[174],"seen":[175],"low-dose":[180],"Co-culture":[182],"change":[187],"phenotype":[189],"these":[194,199],"assays.":[195],"The":[196],"importance":[197],"findings":[200],"possible":[202],"uses":[203],"immunotherapy":[205],"are":[206],"discussed.":[207]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}